Moneycontrol PRO

Cipla — Large part of COVID opportunity has played out

In the US market, Albuterol opportunity remains a key lever for Cipla at least till the time Perrigo re-enters although in terms of market share, the drugmaker may be close to maturity

January 31, 2021 / 01:23 PM IST
Cipla — Large part of COVID opportunity has played out

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Strong performance led by India - In US, Albuterol gains are offset by a product recall -Next drug to watch is Advair, used in the management of pulmonary disease - Margins likely to moderate as operating expenses pick up Cipla (CMP: Rs 826; Market cap: Rs 66,606 crore) — the world’s second largest seller of inhalers — has posted another strong quarter, helped by its respiratory portfolio. The resultant cash flow has helped the company repay loan worth $137 million ahead of schedule and Rs...

  • PRO Panorama

    Moneycontrol Pro Panorama | Rate hike looming, heat is on retail investors

    May 26, 2022 / 06:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama: A midcap in spotlight, warning for stock market, Modi’s three Ts in Tokyo, Start-Up Street and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | History lessons

    May 28, 2022 / 09:29 AM IST

    Why do investors turn to history when the chips are down, but ignore it resolutely during bull markets?

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers